Search

everythinglearnresearchcommunity

for

Search:↓

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Recognizing skin symptoms in children can help diagnose and manage serious diseases early.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

The document concludes that Passiflora incarnata may help with anxiety, healthcare workers need mental support, common bacteria cause hospital UTIs, telehealth for heart failure needs research, kids' screen time has increased, pregnant teens are mostly okay with their body image, diagnosing post-surgery tuberculosis is hard, older and severely ill people are more likely to have long COVID symptoms, and psychiatrists should be part of pain management teams.

The document explains various skin conditions and their treatments.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Combining amino acid and stem cell therapy may help manage hepatocutaneous syndrome in dogs.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

The document says that there are treatments for hair and nail diseases.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.